Atazavanir/Ritonavir-based HAART in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
HIV
Interventions
DRUG

boosted atazanavir (ATV/r)

ATV/r will be taken orally once daily with food plus standard dose of 2 NRTIs according to Thai National HIV treatment guideline

Trial Locations (3)

10330

Department of Pediatrics Faculty of Medicine, Chulalongkorn University, Bangkok

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok

Unknown

Division of Infectious Diseases Department of Pediatrics Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok

All Listed Sponsors
collaborator

amfAR, The Foundation for AIDS Research

OTHER

collaborator

National Health Security Office, Thailand

OTHER

collaborator

The Thai Government Pharmaceutical Organization (GPO)

UNKNOWN

lead

The HIV Netherlands Australia Thailand Research Collaboration

OTHER

NCT01656109 - Atazavanir/Ritonavir-based HAART in Children | Biotech Hunter | Biotech Hunter